562 related articles for article (PubMed ID: 31328430)
1. Stachydrine prevents LPS-induced bone loss by inhibiting osteoclastogenesis via NF-κB and Akt signalling.
Meng J; Zhou C; Zhang W; Wang W; He B; Hu B; Jiang G; Wang Y; Hong J; Li S; He J; Yan S; Yan W
J Cell Mol Med; 2019 Oct; 23(10):6730-6743. PubMed ID: 31328430
[TBL] [Abstract][Full Text] [Related]
2. Dehydrocostus lactone attenuates osteoclastogenesis and osteoclast-induced bone loss by modulating NF-κB signalling pathway.
Hu B; Wu F; Shi Z; He B; Zhao X; Wu H; Yan S
J Cell Mol Med; 2019 Aug; 23(8):5762-5770. PubMed ID: 31225720
[TBL] [Abstract][Full Text] [Related]
3. Diallyl disulfide alleviates inflammatory osteolysis by suppressing osteoclastogenesis
Yang J; Tang R; Yi J; Chen Y; Li X; Yu T; Fei J
FASEB J; 2019 Jun; 33(6):7261-7273. PubMed ID: 30857415
[TBL] [Abstract][Full Text] [Related]
4. Caffeic acid 3,4-dihydroxy-phenethyl ester suppresses receptor activator of NF-κB ligand–induced osteoclastogenesis and prevents ovariectomy-induced bone loss through inhibition of mitogen-activated protein kinase/activator protein 1 and Ca2+–nuclear factor of activated T-cells cytoplasmic 1 signaling pathways.
Wu X; Li Z; Yang Z; Zheng C; Jing J; Chen Y; Ye X; Lian X; Qiu W; Yang F; Tang J; Xiao J; Liu M; Luo J
J Bone Miner Res; 2012 Jun; 27(6):1298-1308. PubMed ID: 22337253
[TBL] [Abstract][Full Text] [Related]
5. Bajijiasu Abrogates Osteoclast Differentiation via the Suppression of RANKL Signaling Pathways through NF-κB and NFAT.
Hong G; Zhou L; Shi X; He W; Wang H; Wei Q; Chen P; Qi L; Tickner J; Lin L; Xu J
Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28106828
[TBL] [Abstract][Full Text] [Related]
6. Andrographolide suppresses RANKL-induced osteoclastogenesis in vitro and prevents inflammatory bone loss in vivo.
Zhai ZJ; Li HW; Liu GW; Qu XH; Tian B; Yan W; Lin Z; Tang TT; Qin A; Dai KR
Br J Pharmacol; 2014 Feb; 171(3):663-75. PubMed ID: 24125472
[TBL] [Abstract][Full Text] [Related]
7. Geraniin suppresses RANKL-induced osteoclastogenesis in vitro and ameliorates wear particle-induced osteolysis in mouse model.
Xiao F; Zhai Z; Jiang C; Liu X; Li H; Qu X; Ouyang Z; Fan Q; Tang T; Qin A; Gu D
Exp Cell Res; 2015 Jan; 330(1):91-101. PubMed ID: 25016282
[TBL] [Abstract][Full Text] [Related]
8. Luteoloside prevents lipopolysaccharide-induced osteolysis and suppresses RANKL-induced osteoclastogenesis through attenuating RANKL signaling cascades.
Song F; Wei C; Zhou L; Qin A; Yang M; Tickner J; Huang Y; Zhao J; Xu J
J Cell Physiol; 2018 Feb; 233(2):1723-1735. PubMed ID: 28681916
[TBL] [Abstract][Full Text] [Related]
9. Epothilone B prevents lipopolysaccharide-induced inflammatory osteolysis through suppressing osteoclastogenesis via STAT3 signaling pathway.
Chen Y; Wang Y; Hu J; Tang Y; Tian Z; Hu W; Zeng F; Tan J; Dai Q; Hou Z; Luo F; Xu J; Dong S
Aging (Albany NY); 2020 Jun; 12(12):11698-11716. PubMed ID: 32527985
[TBL] [Abstract][Full Text] [Related]
10. Taxifolin Inhibits Receptor Activator of NF-κB Ligand-Induced Osteoclastogenesis of Human Bone Marrow-Derived Macrophages in vitro and Prevents Lipopolysaccharide-Induced Bone Loss in vivo.
Zhang HQ; Wang YJ; Yang GT; Gao QL; Tang MX
Pharmacology; 2019; 103(1-2):101-109. PubMed ID: 30522105
[TBL] [Abstract][Full Text] [Related]
11. Artesunate inhibits RANKL-induced osteoclastogenesis and bone resorption in vitro and prevents LPS-induced bone loss in vivo.
Wei CM; Liu Q; Song FM; Lin XX; Su YJ; Xu J; Huang L; Zong SH; Zhao JM
J Cell Physiol; 2018 Jan; 233(1):476-485. PubMed ID: 28294321
[TBL] [Abstract][Full Text] [Related]
12. The effect of metallic magnesium degradation products on osteoclast-induced osteolysis and attenuation of NF-κB and NFATc1 signaling.
Zhai Z; Qu X; Li H; Yang K; Wan P; Tan L; Ouyang Z; Liu X; Tian B; Xiao F; Wang W; Jiang C; Tang T; Fan Q; Qin A; Dai K
Biomaterials; 2014 Aug; 35(24):6299-310. PubMed ID: 24816285
[TBL] [Abstract][Full Text] [Related]
13. Corilagin suppresses RANKL-induced osteoclastogenesis and inhibits oestrogen deficiency-induced bone loss via the NF-κB and PI3K/AKT signalling pathways.
Lu J; Ye C; Huang Y; Huang D; Tang L; Hou W; Kuang Z; Chen Y; Xiao S; Yishake M; He R
J Cell Mol Med; 2020 Sep; 24(18):10444-10457. PubMed ID: 32681612
[TBL] [Abstract][Full Text] [Related]
14. Vinpocetine inhibits RANKL-induced osteoclastogenesis and attenuates ovariectomy-induced bone loss.
Zhu M; Liu H; Sun K; Liu J; Mou Y; Qi D; Zhou C; Abudunaibi M; Tasiken B; Li J; Cheng H; Huang H
Biomed Pharmacother; 2020 Mar; 123():109769. PubMed ID: 31846839
[TBL] [Abstract][Full Text] [Related]
15. Sophorae Flos extract inhibits RANKL-induced osteoclast differentiation by suppressing the NF-κB/NFATc1 pathway in mouse bone marrow cells.
Kim JM; Lee JH; Lee GS; Noh EM; Song HK; Gu DR; Kim SC; Lee SH; Kwon KB; Lee YR
BMC Complement Altern Med; 2017 Mar; 17(1):164. PubMed ID: 28335757
[TBL] [Abstract][Full Text] [Related]
16. Euphorbia factor L1 inhibits osteoclastogenesis by regulating cellular redox status and induces Fas-mediated apoptosis in osteoclast.
Hong SE; Lee J; Seo DH; In Lee H; Ri Park D; Lee GR; Jo YJ; Kim N; Kwon M; Shon H; Kyoung Seo E; Kim HS; Young Lee S; Jeong W
Free Radic Biol Med; 2017 Nov; 112():191-199. PubMed ID: 28774817
[TBL] [Abstract][Full Text] [Related]
17. Curcumin has immunomodulatory effects on RANKL-stimulated osteoclastogenesis in vitro and titanium nanoparticle-induced bone loss in vivo.
Yang C; Zhu K; Yuan X; Zhang X; Qian Y; Cheng T
J Cell Mol Med; 2020 Jan; 24(2):1553-1567. PubMed ID: 31845532
[TBL] [Abstract][Full Text] [Related]
18. Genetic and pharmacological activation of Hedgehog signaling inhibits osteoclastogenesis and attenuates titanium particle-induced osteolysis partly through suppressing the JNK/c-Fos-NFATc1 cascade.
Zhang L; Yang Y; Liao Z; Liu Q; Lei X; Li M; Saijilafu ; Zhang Z; Hong D; Zhu M; Li B; Yang H; Chen J
Theranostics; 2020; 10(15):6638-6660. PubMed ID: 32550895
[No Abstract] [Full Text] [Related]
19. Thymoquinone prevents RANKL-induced osteoclastogenesis activation and osteolysis in an in vivo model of inflammation by suppressing NF-KB and MAPK Signalling.
Thummuri D; Jeengar MK; Shrivastava S; Nemani H; Ramavat RN; Chaudhari P; Naidu VG
Pharmacol Res; 2015 Sep; 99():63-73. PubMed ID: 26022736
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of osteoclastogenesis by histone deacetylase inhibitor Quisinostat protects mice against titanium particle-induced bone loss.
Zhang L; Zhang L; You H; Sun S; Liao Z; Zhao G; Chen J
Eur J Pharmacol; 2021 Aug; 904():174176. PubMed ID: 34004213
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
